{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,2]],"date-time":"2026-11-02T18:15:41Z","timestamp":1793643341608,"version":"4.5.1"},"reference-count":36,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,1,13]],"date-time":"2026-01-13T00:00:00Z","timestamp":1768262400000},"content-version":"am","delay-in-days":377,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100003478","name":"Ministry of Health, Labour and Welfare","doi-asserted-by":"publisher","award":["23AA2007"],"award-info":[{"award-number":["23AA2007"]}],"id":[{"id":"10.13039\/501100003478","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003478","name":"Ministry of Health, Labour and Welfare","doi-asserted-by":"publisher","award":["22AA2003"],"award-info":[{"award-number":["22AA2003"]}],"id":[{"id":"10.13039\/501100003478","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jiac-j.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Infection and Chemotherapy"],"published-print":{"date-parts":[[2025,1]]},"DOI":"10.1016\/j.jiac.2024.08.004","type":"journal-article","created":{"date-parts":[[2024,8,6]],"date-time":"2024-08-06T20:04:38Z","timestamp":1722974678000},"page":"102489","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"title":["Trimethoprim-sulfamethoxazole combined with echinocandins versus trimethoprim-sulfamethoxazole alone for Pneumocystis pneumonia in patients without human immunodeficiency virus infection: A nationwide retrospective cohort study"],"prefix":"10.1016","volume":"31","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2480-9018","authenticated-orcid":false,"given":"Jumpei","family":"Taniguchi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7804-2433","authenticated-orcid":false,"given":"Shotaro","family":"Aso","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroki","family":"Matsui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1894-0290","authenticated-orcid":false,"given":"Kiyohide","family":"Fushimi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hideo","family":"Yasunaga","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jiac.2024.08.004_bib1","doi-asserted-by":"crossref","first-page":"2487","DOI":"10.1056\/NEJMra032588","article-title":"Pneumocystis pneumonia","volume":"350","author":"Thomas","year":"2004","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jiac.2024.08.004_bib2","doi-asserted-by":"crossref","first-page":"1200","DOI":"10.1186\/s12879-021-06895-x","article-title":"Low cut-off value of serum (1,3)-beta-D-glucan for the diagnosis of Pneumocystis pneumonia in non-HIV patients: a retrospective cohort study","volume":"21","author":"Taniguchi","year":"2021","journal-title":"BMC Infect Dis"},{"key":"10.1016\/j.jiac.2024.08.004_bib3","doi-asserted-by":"crossref","first-page":"132","DOI":"10.4046\/trd.2020.0015","article-title":"Recent advances in the diagnosis and management of pneumocystis pneumonia","volume":"83","author":"Tasaka","year":"2020","journal-title":"Tuberc Respir Dis"},{"key":"10.1016\/j.jiac.2024.08.004_bib4","doi-asserted-by":"crossref","first-page":"2386","DOI":"10.1093\/jac\/dkw156","article-title":"ECIL guidelines for the diagnosis of Pneumocystis jirovecii pneumonia in patients with haematological malignancies and stem cell transplant recipients","volume":"71","author":"Alanio","year":"2016","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.jiac.2024.08.004_bib5","doi-asserted-by":"crossref","first-page":"663","DOI":"10.7326\/0003-4819-100-5-663","article-title":"Pneumocystis carinii pneumonia: a comparison between patients with the acquired immunodeficiency syndrome and patients with other immunodeficiencies","volume":"100","author":"Kovacs","year":"1984","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.jiac.2024.08.004_bib6","doi-asserted-by":"crossref","first-page":"704","DOI":"10.1378\/chest.118.3.704","article-title":"Management and outcome patterns for adult Pneumocystis carinii pneumonia, 1985 to 1995: comparison of HIV-associated cases to other immunocompromised states","volume":"118","author":"Mansharamani","year":"2000","journal-title":"Chest"},{"key":"10.1016\/j.jiac.2024.08.004_bib7","doi-asserted-by":"crossref","first-page":"1098","DOI":"10.1086\/339548","article-title":"Opportunistic infections in patients with and patients without acquired immunodeficiency syndrome","volume":"34","author":"Sepkowitz","year":"2002","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.jiac.2024.08.004_bib8","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0008524","article-title":"Echinocandin treatment of pneumocystis pneumonia in rodent models depletes cysts leaving trophic burdens that cannot transmit the infection","volume":"5","author":"Cushion","year":"2010","journal-title":"PLoS One"},{"key":"10.1016\/j.jiac.2024.08.004_bib9","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1186\/s12879-023-08372-z","article-title":"Efficacy of initial caspofungin plus trimethoprim\/sulfamethoxazole for severe PCP in patients without human immunodeficiency virus infection","volume":"23","author":"Qi","year":"2023","journal-title":"BMC Infect Dis"},{"key":"10.1016\/j.jiac.2024.08.004_bib10","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1080\/1120009X.2022.2095155","article-title":"Meta-analysis of echinocandins combined with trimethoprim-sulfamethoxazole for treatment of Pneumocystis pneumonia","volume":"35","author":"Guo","year":"2023","journal-title":"J Chemother"},{"key":"10.1016\/j.jiac.2024.08.004_bib11","doi-asserted-by":"crossref","first-page":"719","DOI":"10.3390\/antibiotics11060719","article-title":"Efficacy of trimethoprim-sulfamethoxazole in combination with an echinocandin as a first-line treatment option for pneumocystis pneumonia: a systematic review and meta-analysis","volume":"11","author":"Kato","year":"2022","journal-title":"Antibiotics (Basel)"},{"key":"10.1016\/j.jiac.2024.08.004_bib12","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1111\/hiv.13013","article-title":"Caspofungin combined with TMP\/SMZ as a first-line therapy for moderate-to-severe PCP in patients with human immunodeficiency virus infection","volume":"22","author":"Tian","year":"2021","journal-title":"HIV Med"},{"key":"10.1016\/j.jiac.2024.08.004_bib13","doi-asserted-by":"crossref","DOI":"10.1155\/2019\/8105075","article-title":"A pilot study of echinocandin combination with trimethoprim\/sulfamethoxazole and clindamycin for the treatment of AIDS patients with pneumocystis pneumonia","volume":"2019","author":"Wang","year":"2019","journal-title":"J Immunol Res"},{"key":"10.1016\/j.jiac.2024.08.004_bib14","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/j.ijid.2019.08.015","article-title":"High initial (1, 3) Beta-d-Glucan concentration may be a predictor of satisfactory response of caspofungin combined with TMP\/SMZ for HIV-negative patients with moderate to severe Pneumocystis jirovecii pneumonia","volume":"88","author":"Jin","year":"2019","journal-title":"Int J Infect Dis"},{"key":"10.1016\/j.jiac.2024.08.004_bib15","doi-asserted-by":"crossref","first-page":"1893","DOI":"10.1016\/j.transproceed.2017.04.020","article-title":"Combination of echinocandins and trimethoprim\/sulfamethoxazole for the treatment of pneumocystis jiroveci pneumonia after heart transplantation","volume":"49","author":"Lu","year":"2017","journal-title":"Transplant Proc"},{"key":"10.1016\/j.jiac.2024.08.004_bib16","doi-asserted-by":"crossref","first-page":"484","DOI":"10.3109\/00365548.2012.760842","article-title":"Is caspofungin really an effective treatment for Pneumocystis jirovecii pneumonia in immunocompromised patients without human immunodeficiency virus infection? Experiences at a single center and a literature review","volume":"45","author":"Kim","year":"2013","journal-title":"Scand J Infect Dis"},{"key":"10.1016\/j.jiac.2024.08.004_bib17","first-page":"81","article-title":"Diagnosis Procedure Combination as an infrastructure for the clinical study","volume":"5","author":"Matsuda","year":"2011","journal-title":"Asian Pac J Dis Manag"},{"key":"10.1016\/j.jiac.2024.08.004_bib18","doi-asserted-by":"crossref","first-page":"76","DOI":"10.37737\/ace.1.3_76","article-title":"Real world data in Japan: chapter II the diagnosis procedure combination database","volume":"1","author":"Yasunaga","year":"2019","journal-title":"Ann Clin Epidemiol"},{"key":"10.1016\/j.jiac.2024.08.004_bib19","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1016\/j.je.2016.09.009","article-title":"Validity of diagnoses, procedures, and laboratory data in Japanese administrative data","volume":"27","author":"Yamana","year":"2017","journal-title":"J Epidemiol"},{"key":"10.1016\/j.jiac.2024.08.004_bib20","first-page":"61","article-title":"Functional evaluation: the barthel index","volume":"14","author":"Mahoney","year":"1965","journal-title":"Md State Med J"},{"key":"10.1016\/j.jiac.2024.08.004_bib21","doi-asserted-by":"crossref","first-page":"531","DOI":"10.2188\/jea.JE20220147","article-title":"Development and validation of a novel method for converting the Japan coma Scale to Glasgow coma Scale","volume":"33","author":"Nakajima","year":"2023","journal-title":"J Epidemiol"},{"key":"10.1016\/j.jiac.2024.08.004_bib22","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2013-002736","article-title":"The eye response test alone is sufficient to predict stroke outcome--reintroduction of Japan Coma Scale: a cohort study","volume":"3","author":"Shigematsu","year":"2013","journal-title":"BMJ Open"},{"key":"10.1016\/j.jiac.2024.08.004_bib23","doi-asserted-by":"crossref","first-page":"1225","DOI":"10.1016\/j.cmi.2023.05.004","article-title":"Which trial do we need? Combination treatment of Pneumocystis jirovecii pneumonia in non-HIV infected patients","volume":"29","author":"Koehler","year":"2023","journal-title":"Clin Microbiol Infect"},{"key":"10.1016\/j.jiac.2024.08.004_bib24","article-title":"Alternative approaches for confounding adjustment in observational studies using weighting based on the propensity score: a primer for practitioners","volume":"367","author":"Desai","year":"2019","journal-title":"BMJ"},{"key":"10.1016\/j.jiac.2024.08.004_bib25","doi-asserted-by":"crossref","first-page":"2417","DOI":"10.1001\/jama.2020.7819","article-title":"Overlap weighting: a propensity score method that mimics attributes of a randomized clinical trial","volume":"323","author":"Thomas","year":"2020","journal-title":"JAMA"},{"key":"10.1016\/j.jiac.2024.08.004_bib26","doi-asserted-by":"crossref","first-page":"3083","DOI":"10.1002\/sim.3697","article-title":"Balance diagnostics for comparing the distribution of baseline covariates between treatment groups in propensity-score matched samples","volume":"28","author":"Austin","year":"2009","journal-title":"Stat Med"},{"key":"10.1016\/j.jiac.2024.08.004_bib27","doi-asserted-by":"crossref","first-page":"3661","DOI":"10.1002\/sim.6607","article-title":"Moving towards best practice when using inverse probability of treatment weighting (IPTW) using the propensity score to estimate causal treatment effects in observational studies","volume":"34","author":"Austin","year":"2015","journal-title":"Stat Med"},{"key":"10.1016\/j.jiac.2024.08.004_bib28","doi-asserted-by":"crossref","first-page":"1811","DOI":"10.1128\/AAC.40.8.1811","article-title":"Semisynthetic echinocandins affect cell wall deposition of Pneumocystis carinii in vitro and in vivo","volume":"40","author":"Bartlett","year":"1996","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.jiac.2024.08.004_bib29","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1093\/jac\/dkg117","article-title":"Caspofungin: the first representative of a new antifungal class","volume":"51","author":"Letscher-Bru","year":"2003","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.jiac.2024.08.004_bib30","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1007\/s10096-005-0065-z","article-title":"Caspofungin treatment of Pneumocystis pneumonia during conditioning for bone marrow transplantation","volume":"25","author":"Annaloro","year":"2006","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"10.1016\/j.jiac.2024.08.004_bib31","doi-asserted-by":"crossref","first-page":"e92","DOI":"10.1086\/508282","article-title":"Progression of Pneumocystis jiroveci pneumonia in patients receiving echinocandin therapy","volume":"43","author":"Kamboj","year":"2006","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.jiac.2024.08.004_bib32","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1136\/thx.2010.135350","article-title":"A trial of caspofungin salvage treatment in PCP pneumonia","volume":"66","author":"Armstrong-James","year":"2011","journal-title":"Thorax"},{"key":"10.1016\/j.jiac.2024.08.004_bib33","doi-asserted-by":"crossref","first-page":"1345","DOI":"10.1097\/QAD.0000000000002207","article-title":"Echinocandins as alternative treatment for HIV-infected patients with Pneumocystis pneumonia","volume":"33","author":"Huang","year":"2019","journal-title":"AIDS"},{"key":"10.1016\/j.jiac.2024.08.004_bib34","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1038\/nrmicro1621","article-title":"Current insights into the biology and pathogenesis of Pneumocystis pneumonia","volume":"5","author":"Thomas","year":"2007","journal-title":"Nat Rev Microbiol"},{"key":"10.1016\/j.jiac.2024.08.004_bib35","doi-asserted-by":"crossref","first-page":"1204","DOI":"10.1164\/ajrccm\/140.5.1204","article-title":"Pneumocystis carinii pneumonia. Differences in lung parasite number and inflammation in patients with and without AIDS","volume":"140","author":"Limper","year":"1989","journal-title":"Am Rev Respir Dis"},{"issue":"Suppl 2","key":"10.1016\/j.jiac.2024.08.004_bib36","article-title":"Pneumocystis jirovecii disease: basis for the revised EORTC\/MSGERC invasive fungal disease definitions in individuals without human immunodeficiency virus","volume":"72","author":"Lagrou","year":"2021","journal-title":"Clin Infect Dis"}],"container-title":["Journal of Infection and Chemotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1341321X24002137?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1341321X24002137?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,12]],"date-time":"2026-05-12T13:55:45Z","timestamp":1778594145000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1341321X24002137"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1]]},"references-count":36,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2025,1]]}},"alternative-id":["S1341321X24002137"],"URL":"https:\/\/doi.org\/10.1016\/j.jiac.2024.08.004","relation":{},"ISSN":["1341-321X"],"issn-type":[{"value":"1341-321X","type":"print"}],"subject":[],"published":{"date-parts":[[2025,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Trimethoprim-sulfamethoxazole combined with echinocandins versus trimethoprim-sulfamethoxazole alone for Pneumocystis pneumonia in patients without human immunodeficiency virus infection: A nationwide retrospective cohort study","name":"articletitle","label":"Article Title"},{"value":"Journal of Infection and Chemotherapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jiac.2024.08.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Japanese Society of Chemotherapy, Japanese Association for Infectious Diseases, and Japanese Society for Infection Prevention and Control. Published by Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"102489"}}